SGV: SANGIVAMYCIN
SGV is a Ligand Of Interest in 3NYN designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3NYN_SGV_B_577 | 41% | 22% | 0.24 | 0.958 | 1.31 | 1.93 | 2 | 5 | 0 | 0 | 100% | 1 |
| 3NYN_SGV_A_577 | 31% | 23% | 0.293 | 0.965 | 1.34 | 1.8 | 2 | 3 | 0 | 0 | 100% | 1 |
| 4TNB_SGV_A_601 | 83% | 4% | 0.096 | 0.956 | 2.33 | 3.46 | 7 | 6 | 0 | 0 | 100% | 1 |
| 8OV2_SGV_A_7222 | 83% | 3% | 0.088 | 0.947 | 4.05 | 2.27 | 12 | 7 | 0 | 0 | 100% | 1 |
| 6C9N_SGV_A_401 | 83% | 17% | 0.112 | 0.97 | 2.04 | 1.59 | 5 | 4 | 0 | 0 | 100% | 1 |
| 6PJX_SGV_A_601 | 79% | 3% | 0.131 | 0.976 | 2.17 | 3.92 | 7 | 7 | 0 | 0 | 100% | 1 |
| 5AQZ_SGV_A_1389 | 78% | 55% | 0.085 | 0.926 | 0.94 | 0.8 | 2 | 1 | 0 | 0 | 100% | 1 |
